| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +290,000 | 100% | $2.45 | +$710,500 |
| Sells | 0 | ||||
| Net | +1 | +290,000 | 100% | +$710,500 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Gary W. Pace | Director | $6,557,062 | +$710,500 | +12% | 30 Jul 2025 |
| Vicki Kelemen | Exec. VP and COO | $1,815,590 | 15 Mar 2023 | ||
| Thomas Adams PhD | Former Director | $1,242,462 | 10 Jun 2021 | ||
| Katherine L. Ruffner | Chief Medical Officer | $962,042 | 09 Mar 2022 | ||
| Rodney S. Markin | Director | $473,270 | 26 Jun 2025 | ||
| Renee P. Tannenbaum | Director | $401,771 | 26 Jun 2025 | ||
| Armitage James O | Director | $382,132 | 26 Jun 2025 | ||
| Lale White | Director | $382,132 | 26 Jun 2025 | ||
| James E. Levine | Chief Financial Officer | $338,580 | 11 Mar 2025 | ||
| John P. Brancaccio | Former Director | $325,824 | 09 Jun 2022 | ||
| Gary S. Jacob | Former Director | $197,876 | 10 Jun 2021 | ||
| Brigitte Ute Lindsay | Chief Accounting Officer | $78,726 | 13 Feb 2026 | ||
| Mani Mohindru | Interim CEO, Director | 17 Feb 2026 | |||
| Fairooz Kabbinavar | Chief Medical Officer | 11 Mar 2025 | |||
| Tod Smeal | Chief Scientific Officer | 11 Mar 2025 | |||
| Mark Erlander | Chief Executive Officer, Director | 11 Mar 2025 | |||
| Roger Sidhu | Chief Medical Officer | 16 Jun 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Mani Mohindru | CRDF | Stock Options | Award | 118.5% | 200,000 | 368,766 | 17 Feb 2026 | Direct | ||
| Brigitte Ute Lindsay | CRDF | Stock Options | Award | 24.2% | 200,000 | 1,025,334 | 13 Feb 2026 | Direct | ||
| Gary W. Pace | CRDF | Common Stock | Purchase | 1.13% | $36,750 | $2.45 | 15,000 | 1,345,676 | 30 Jul 2025 | By minor child |
| Gary W. Pace | CRDF | Common Stock | Purchase | 26% | $673,750 | $2.45 | 275,000 | 1,330,676 | 30 Jul 2025 | Direct |
| Renee P. Tannenbaum | CRDF | Stock Options | Award | 31.6% | 40,565 | 168,766 | 26 Jun 2025 | Direct | ||
| Rodney S. Markin | CRDF | Stock Options | Award | 22.2% | 40,565 | 222,865 | 26 Jun 2025 | Direct | ||
| Mani Mohindru | CRDF | Stock Options | Award | 31.6% | 40,565 | 168,766 | 26 Jun 2025 | Direct | ||
| Armitage James O | CRDF | Stock Options | Award | 27.6% | 40,565 | 187,539 | 26 Jun 2025 | Direct | ||
| Lale White | CRDF | Stock Options | Award | 34.3% | 40,565 | 158,681 | 26 Jun 2025 | Direct | ||
| Gary W. Pace | CRDF | Stock Options | Award | 27.6% | 40,565 | 187,539 | 26 Jun 2025 | Direct | ||
| Fairooz Kabbinavar | CRDF | Stock Options | Award | 23.8% | 150,000 | 780,008 | 11 Mar 2025 | Direct | ||
| James E. Levine | CRDF | Stock Options | Award | 34.6% | 332,621 | 1,295,117 | 11 Mar 2025 | Direct | ||
| Tod Smeal | CRDF | Stock Options | Award | 51.4% | 332,621 | 979,805 | 11 Mar 2025 | Direct | ||
| Mark Erlander | CRDF | Stock Options | Award | 35% | 758,400 | 2,925,098 | 11 Mar 2025 | Direct | ||
| James E. Levine | CRDF | Common Stock | Purchase | 3.67% | $12,000 | $5.00 | 2,400 | 67,716 | 18 Dec 2024 | By Wife |
| James E. Levine | CRDF | Common Stock | Purchase | 4.4% | $14,905 | $5.42 | 2,752 | 65,316 | 17 Dec 2024 | By Wife |
| James E. Levine | CRDF | Common Stock | Purchase | 4.27% | $9,820 | $3.83 | 2,564 | 62,564 | 16 Dec 2024 | By Wife |
| Renee P. Tannenbaum | CRDF | Common Stock | Purchase | 100% | $34,224 | $3.42 | 10,000 | 20,000 | 12 Dec 2024 | Direct |
| Gary W. Pace | CRDF | Common Stock | Purchase | 1.1% | $29,900 | $2.60 | 11,500 | 1,059,376 | 11 Dec 2024 | By minor child |
| Gary W. Pace | CRDF | Common Stock | Purchase | 50.2% | $910,299 | $2.60 | 350,115 | 1,047,876 | 11 Dec 2024 | Direct |
| Lale White | CRDF | Stock Options | Award | 25.3% | 29,700 | 146,974 | 27 Jun 2024 | Direct | ||
| Renee P. Tannenbaum | CRDF | Stock Options | Award | 30.2% | 29,700 | 128,201 | 27 Jun 2024 | Direct | ||
| Mani Mohindru | CRDF | Stock Options | Award | 30.2% | 29,700 | 128,201 | 27 Jun 2024 | Direct | ||
| Gary W. Pace | CRDF | Stock Options | Award | 25.3% | 29,700 | 146,974 | 27 Jun 2024 | Direct | ||
| Armitage James O | CRDF | Stock Options | Award | 25.3% | 29,700 | 146,974 | 27 Jun 2024 | Direct | ||
| Rodney S. Markin | CRDF | Stock Options | Award | 19.5% | 29,700 | 182,027 | 27 Jun 2024 | Direct | ||
| James E. Levine | CRDF | Stock Options | Award | 27.1% | 205,008 | 962,496 | 07 Mar 2024 | Direct | ||
| Fairooz Kabbinavar | CRDF | Stock Options | Award | 48.2% | 205,008 | 630,008 | 07 Mar 2024 | Direct | ||
| Tod Smeal | CRDF | Stock Options | Award | 46.4% | 205,008 | 647,184 | 07 Mar 2024 | Direct | ||
| Mark Erlander | CRDF | Stock Options | Award | 30.7% | 510,000 | 2,170,310 | 07 Mar 2024 | Direct | ||
| Gary W. Pace | CRDF | Common Stock | Purchase | 4.49% | $41,100 | $1.37 | 30,000 | 697,761 | 19 Dec 2023 | Direct |
| Gary W. Pace | CRDF | Common Stock | Purchase | 3.56% | $22,491 | $0.9800 | 22,950 | 667,761 | 10 Nov 2023 | Direct |
| Rodney S. Markin | CRDF | Stock Options | Award | 22.2% | 27,700 | 152,327 | 15 Jun 2023 | Direct | ||
| Armitage James O | CRDF | Stock Options | Award | 30.9% | 27,700 | 117,274 | 15 Jun 2023 | Direct | ||
| Mani Mohindru | CRDF | Stock Options | Award | 39.1% | 27,700 | 98,501 | 15 Jun 2023 | Direct | ||
| Renee P. Tannenbaum | CRDF | Stock Options | Award | 39.1% | 27,700 | 98,501 | 15 Jun 2023 | Direct | ||
| Lale White | CRDF | Stock Options | Award | 30.9% | 27,700 | 117,274 | 15 Jun 2023 | Direct | ||
| Gary W. Pace | CRDF | Stock Options | Award | 30.9% | 27,700 | 117,274 | 15 Jun 2023 | Direct | ||
| Tod Smeal | CRDF | Stock Options | Award | 60.7% | 167,088 | 442,176 | 15 Mar 2023 | Direct | ||
| James E. Levine | CRDF | Stock Options | Award | 35.3% | 197,472 | 757,488 | 15 Mar 2023 | Direct | ||
| Vicki Kelemen | CRDF | Stock Options | Award | 21.9% | 125,520 | 698,304 | 15 Mar 2023 | Direct | ||
| Mark Erlander | CRDF | Stock Options | Award | 40.8% | 482,064 | 1,664,477 | 15 Mar 2023 | Direct | ||
| Mark Erlander | CRDF | Common Stock | Purchase | 69.1% | $14,300 | $1.43 | 10,000 | 24,481 | 25 Nov 2022 | Direct |
| Lale White | CRDF | Common Stock | Purchase | 15.2% | $24,525 | $1.64 | 15,000 | 113,788 | 19 Sep 2022 | Trust |
| Armitage James O | CRDF | Common Stock | Purchase | $20,233 | $1.56 | 13,000 | 13,000 | 16 Sep 2022 | Trust | |
| James E. Levine | CRDF | Common Stock | Purchase | 100% | $46,710 | $1.56 | 30,000 | 60,000 | 16 Sep 2022 | Direct |
| Renee P. Tannenbaum | CRDF | Common Stock | Purchase | $17,168 | $1.72 | 10,000 | 10,000 | 15 Sep 2022 | Direct | |
| Gary W. Pace | CRDF | Common Stock | Purchase | 30.3% | $256,500 | $1.71 | 150,000 | 644,811 | 15 Sep 2022 | Direct |
| Lale White | CRDF | Common Stock | Options Exercise | 41.3% | 28,858 | 98,788 | 05 Jul 2022 | Trust | ||
| Lale White | CRDF | Stock Options | Options Exercise | -32.2% | -28,858 | 60,716 | 05 Jul 2022 | Direct |